Search

Author/Creator Shapiro, David

1. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Issue 5 (29th January 2018)

Authors:
Kowdley, Kris V.; Luketic, Velimir; Chapman, Roger; Hirschfield, Gideon M.; Poupon, Raoul; Schramm, Christoph; Vincent, Catherine; Rust, Christian; Parés, Albert; Mason, Andrew; Marschall, Hanns‐Ulrich; Shapiro, David; Adorini, Luciano; Sciacca, Cathi; Beecher‐Jones, Tessa; Böhm, Olaf; Pencek, Ri...
Journal:
Hepatology
Issue:
Volume 67:Issue 5(2018)
Page Start:
1890
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Spore‐Forming Probiotic Supplement Improves the Intestinal Immune Response and Protects the Intestinal Health During Recurrent Clostridioides difficile Colonization in Mice. Issue 8 (4th June 2020)

Authors:
Ramezani Kapourchali, Fatemeh; Glueck, Bryan; Han, Yingchun; Shapiro, David; Fulmer, Clifton G.; Cresci, Gail A. M.
Journal:
JPEN, Journal of parenteral and enteral nutrition
Issue:
Volume 44:Issue 8(2020)
Page Start:
1428
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis. Issue 6 (19th April 2018)

Authors:
Carbone, Marco; Harms, Maren H.; Lammers, Willem J.; Marmon, Tonya; Pencek, Richard; MacConell, Leigh; Shapiro, David; Jones, David E.; Mells, George F.; Hansen, Bettina E.
Journal:
Hepatology communications
Issue:
Volume 2:Issue 6(2018)
Page Start:
683
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗